Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
DEXCOM INC
Report date July 30, 2018 · Filed August 03, 2018
Section 16 reporting ended · disclosed 2018-08-03. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 16, 2018 Filed Jul 18, 2018 21:50 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 500 | $100.73 | $50,365.00 |
DisclosureSEC source: 0001093557-18-000148 · edgardoc.xml · nonDerivative · entry 3 GREGG TERRANCE H · CIK 0001236388 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 50,882 F1 · shares: On December 5, 2017, Mr. Gregg adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Gregg. The shares set forth above were sold pursuant to the 10b5-1 Plan. F3 · ownership.nature: Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee. Read SEC document |
| July 16, 2018 Filed Jul 18, 2018 21:50 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 3,900 | $99.87 | $389,496.12 |
DisclosureSEC source: 0001093557-18-000148 · edgardoc.xml · nonDerivative · entry 2 GREGG TERRANCE H · CIK 0001236388 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 51,382 F1 · shares: On December 5, 2017, Mr. Gregg adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Gregg. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $99.64 to $100.08. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee. Read SEC document |
| July 16, 2018 Filed Jul 18, 2018 21:50 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 5,600 | $99.23 | $555,700.32 |
DisclosureSEC source: 0001093557-18-000148 · edgardoc.xml · nonDerivative · entry 1 GREGG TERRANCE H · CIK 0001236388 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 55,282 F1 · shares: On December 5, 2017, Mr. Gregg adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Gregg. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $98.64 and $99.63. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee. Read SEC document |
| June 15, 2018 Filed Jun 20, 2018 00:37 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 10,000 | $97.81 | $978,096.00 |
DisclosureSEC source: 0001093557-18-000125 · edgardoc.xml · nonDerivative · entry 1 GREGG TERRANCE H · CIK 0001236388 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 882 F1 · shares: On December 5, 2017, Mr. Gregg adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Gregg. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $96.87 and $98.77. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee. Read SEC document |
| May 15, 2018 Filed May 17, 2018 22:49 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 10,000 | $85.90 | $858,974.00 |
DisclosureSEC source: 0001093557-18-000097 · edgardoc.xml · nonDerivative · entry 1 GREGG TERRANCE H · CIK 0001236388 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 882 F1 · shares: On December 5, 2017, Mr. Gregg adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Gregg. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $85.49 and $86.65. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee. Read SEC document |
| April 16, 2018 Filed Apr 18, 2018 23:24 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 10,000 | $73.04 | $730,414.00 |
DisclosureSEC source: 0001093557-18-000070 · edgardoc.xml · nonDerivative · entry 1 GREGG TERRANCE H · CIK 0001236388 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 882 F1 · shares: On December 5, 2017, Mr. Gregg adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Gregg. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $72.38 and $73.40. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee. Read SEC document |
| March 15, 2018 Filed Mar 20, 2018 00:08 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 10,000 | $65.51 | $655,122.00 |
DisclosureSEC source: 0001093557-18-000066 · edgardoc.xml · nonDerivative · entry 1 GREGG TERRANCE H · CIK 0001236388 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 10,882 F1 · shares: On December 5, 2017, Mr. Gregg adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Gregg. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $64.15 and $65.94. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee. Read SEC document |
| March 12, 2018 Filed Mar 15, 2018 01:02 UTC | DEXCOM INC DXCM · Entity 3114 | Disposition to issuerCommon Stock | 9,972 | $60.73 | $605,605.54 |
DisclosureSEC source: 0001093557-18-000054 · edgardoc.xml · nonDerivative · entry 1 GREGG TERRANCE H · CIK 0001236388 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 521,674 F1 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F2 · balance_after: Included in this number are 47,087 unvested restricted stock units which were granted on March 8, 2018 and shall vest through March 8, 2021. Read SEC document |
| March 08, 2018 Filed Mar 13, 2018 01:31 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 47,087 | $0.00 | $47.09 |
DisclosureSEC source: 0001093557-18-000033 · edgardoc.xml · nonDerivative · entry 1 GREGG TERRANCE H · CIK 0001236388 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 531,646 F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting over a 36 month period from the date of grant as follows: 1/3 shall vest 12 months from the Grant Date, and the remaining balance shall vest in four equal installments over the following 24 months. Share units represent a contingent right to receive one share of DexCom, Inc. common stock. F2 · balance_after: Included in this number are 47,087 unvested restricted stock units which were granted on March 8, 2018 and shall vest through March 8, 2021. Read SEC document |
| February 15, 2018 Filed Feb 21, 2018 01:14 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 10,000 | $55.91 | $559,095.00 |
DisclosureSEC source: 0001093557-18-000009 · edgardoc.xml · nonDerivative · entry 1 GREGG TERRANCE H · CIK 0001236388 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 20,882 F1 · shares: On December 5, 2017, Mr. Gregg adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Gregg. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $55.64 and $56.25. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee. Read SEC document |
| January 16, 2018 Filed Jan 19, 2018 01:21 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 10,000 | $56.86 | $568,588.00 |
DisclosureSEC source: 0001093557-18-000005 · edgardoc.xml · nonDerivative · entry 1 GREGG TERRANCE H · CIK 0001236388 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 30,882 F1 · shares: On December 5, 2017, Mr. Gregg adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Gregg. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $56.44 and $57.36. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee. Read SEC document |
| May 24, 2017 Filed May 26, 2017 20:24 UTC | DEXCOM INC DXCM · Entity 3114 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $6.85 | $0.00 |
DisclosureSEC source: 0001093557-17-000131 · edgardoc.xml · derivative · entry 4 GREGG TERRANCE H · CIK 0001236388 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2017-06-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2017 Filed May 26, 2017 20:24 UTC | DEXCOM INC DXCM · Entity 3114 | Exercise / conversionCommon Stock | 30,000 | $6.85 | $205,500.00 |
DisclosureSEC source: 0001093557-17-000131 · edgardoc.xml · nonDerivative · entry 1 GREGG TERRANCE H · CIK 0001236388 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 484,559 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Included in this number are 30,877 unvested restricted stock units which were granted on March 8, 2017 and shall vest on March 8, 2018. Read SEC document |
| April 20, 2017 Filed Apr 24, 2017 22:13 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 15,000 | $74.10 | $1,111,500.00 |
DisclosureSEC source: 0001093557-17-000103 · edgardoc.xml · nonDerivative · entry 1 GREGG TERRANCE H · CIK 0001236388 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 40,882 F1 · shares: The reporting person contributed Dexcom, Inc. Common Stock to an exchange fund, pursuant to an agreement dated March 13, 2017 to contribute shares of DexCom, Inc. Common Stock in exchange for shares of the exchange fund. The Dexcom, Inc. Common Stock was valued at $74.10 per share for the purposes of determining the number of shares of the exchange fund issuable to the reporting person with respect to the April 20, 2017 closing of the exchange fund. F2 · ownership.nature: Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee. Read SEC document |
| March 10, 2017 Filed Mar 11, 2017 01:48 UTC | DEXCOM INC DXCM · Entity 3114 | Disposition to issuerCommon Stock | 14,512 | $77.55 | $1,125,414.31 |
DisclosureSEC source: 0001093557-17-000063 · edgardoc.xml · nonDerivative · entry 3 GREGG TERRANCE H · CIK 0001236388 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 454,559 F3 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F2 · balance_after: Included in this number are 30,877 unvested restricted stock units which were granted on March 8, 2017 and shall vest on March 8, 2018. Read SEC document |
| March 10, 2017 Filed Mar 11, 2017 01:48 UTC | DEXCOM INC DXCM · Entity 3114 | Disposition to issuerCommon Stock | 1,661 | $77.55 | $128,811.55 |
DisclosureSEC source: 0001093557-17-000063 · edgardoc.xml · nonDerivative · entry 2 GREGG TERRANCE H · CIK 0001236388 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 469,071 F3 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F2 · balance_after: Included in this number are 30,877 unvested restricted stock units which were granted on March 8, 2017 and shall vest on March 8, 2018. Read SEC document |
| March 08, 2017 Filed Mar 11, 2017 01:48 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 30,887 | $0.00 | $30.89 |
DisclosureSEC source: 0001093557-17-000063 · edgardoc.xml · nonDerivative · entry 1 GREGG TERRANCE H · CIK 0001236388 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 470,732 F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting over a 36 month period from the date of grant as follows: 1/3 shall vest 12 months from the Grant Date, and the remaining balance shall vest in four equal installments over the following 24 months. Share units represent a contingent right to receive one share of DexCom, Inc. common stock. F2 · balance_after: Included in this number are 30,877 unvested restricted stock units which were granted on March 8, 2017 and shall vest on March 8, 2018. Read SEC document |
| February 09, 2017 Filed Feb 14, 2017 00:18 UTC | DEXCOM INC DXCM · Entity 3114 | Disposition to issuerCommon Stock | 1,421 | $79.35 | $112,756.35 |
DisclosureSEC source: 0001093557-17-000027 · edgardoc.xml · nonDerivative · entry 1 GREGG TERRANCE H · CIK 0001236388 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 439,845 F1 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F2 · balance_after: Included in this number are 39,079 unvested restricted stock units, 34,000 of which were granted on March 8, 2016 and will vest on March 8, 2017 and 5,079 unvested restricted stock units granted on March 8, 2014 and shall vest on March 8, 2017. Read SEC document |
| January 09, 2017 Filed Jan 12, 2017 00:31 UTC | DEXCOM INC DXCM · Entity 3114 | Disposition to issuerCommon Stock | 1,511 | $63.50 | $95,948.50 |
DisclosureSEC source: 0001093557-17-000005 · edgardoc.xml · nonDerivative · entry 1 GREGG TERRANCE H · CIK 0001236388 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 441,266 F1 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F2 · balance_after: Included in this number are 44,157 unvested restricted stock units, 34,000 of which were granted on March 8, 2016 and will vest on March 8, 2017 and 10,157 unvested restricted stock units granted on March 8, 2014, 5,078 of which shall vest each month through March 8, 2017. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 22:46 UTC | DEXCOM INC DXCM · Entity 3114 | GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-16-000764 · edgardoc.xml · nonDerivative · entry 1 GREGG TERRANCE H · CIK 0001236388 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 55,882 F1 · shares: This transaction represents a gift of securities made by the reporting person to a donor-advised fund. This is not a market transaction, thus no price has been reported. Transferor retains no beneficial or voting interest in the transferred shares. F2 · ownership.nature: Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee. Read SEC document |
| December 09, 2016 Filed Dec 13, 2016 00:58 UTC | DEXCOM INC DXCM · Entity 3114 | Disposition to issuerCommon Stock | 2,167 | $64.46 | $139,684.82 |
DisclosureSEC source: 0001093557-16-000756 · edgardoc.xml · nonDerivative · entry 1 GREGG TERRANCE H · CIK 0001236388 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 442,777 F1 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F2 · balance_after: Included in this number are 49,235 unvested restricted stock units, 34,000 of which were granted on March 8, 2016 and will vest on March 8, 2017 and 15,235 unvested restricted stock units granted on March 8, 2014, 5,078 of which shall vest each month through March 8, 2017. Read SEC document |
| November 09, 2016 Filed Nov 14, 2016 23:32 UTC | DEXCOM INC DXCM · Entity 3114 | Disposition to issuerCommon Stock | 2,172 | $62.17 | $135,041.71 |
DisclosureSEC source: 0001093557-16-000750 · edgardoc.xml · nonDerivative · entry 1 GREGG TERRANCE H · CIK 0001236388 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 444,944 F1 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F2 · balance_after: Included in this number are 54,313 unvested restricted stock units, 34,000 of which were granted on March 8, 2016 and will vest on March 8, 2017 and 20,313 unvested restricted stock units granted on March 8, 2014, 5,078 of which shall vest each month through March 8, 2017. Read SEC document |
| October 10, 2016 Filed Oct 13, 2016 00:56 UTC | DEXCOM INC DXCM · Entity 3114 | Disposition to issuerCommon Stock | 2,167 | $83.35 | $180,619.45 |
DisclosureSEC source: 0001093557-16-000721 · edgardoc.xml · nonDerivative · entry 1 GREGG TERRANCE H · CIK 0001236388 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 447,116 F1 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F2 · balance_after: Included in this number are 59,391 unvested restricted stock units, 34,000 of which were granted on March 8, 2016 and will vest on March 8, 2017 and 25,391 unvested restricted stock units granted on March 8, 2014, 5,078 of which shall vest each month through March 8, 2017. Read SEC document |
| September 09, 2016 Filed Sep 14, 2016 00:29 UTC | DEXCOM INC DXCM · Entity 3114 | Disposition to issuerCommon Stock | 2,203 | $93.72 | $206,470.89 |
DisclosureSEC source: 0001093557-16-000689 · edgardoc.xml · nonDerivative · entry 1 GREGG TERRANCE H · CIK 0001236388 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 449,283 F1 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F2 · balance_after: Included in this number are 64,469 unvested restricted stock units, 34,000 of which were granted on March 8, 2016 and will vest on March 8, 2017 and 30,469 unvested restricted stock units granted on March 8, 2014, 5,078 of which shall vest each month through March 8, 2017. Read SEC document |
| September 08, 2016 Filed Sep 10, 2016 00:48 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 5,145 | $95.59 | $491,829.59 |
DisclosureSEC source: 0001093557-16-000676 · edgardoc.xml · nonDerivative · entry 2 GREGG TERRANCE H · CIK 0001236388 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 65,882 F3 · price: This transaction was executed in multiple trades at prices ranging from $95.46 to $95.77. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · ownership.nature: Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee. Read SEC document |
| September 07, 2016 Filed Sep 10, 2016 00:48 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 5,595 | $95.01 | $531,570.88 |
DisclosureSEC source: 0001093557-16-000676 · edgardoc.xml · nonDerivative · entry 1 GREGG TERRANCE H · CIK 0001236388 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 71,027 F1 · price: This transaction was executed in multiple trades at prices ranging from $95.00 and $95.04. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · ownership.nature: Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.